Gene-Modified Stem Cell Transplant Protects Patients from Toxic Side Effects ... Science Daily (press release) As many as 50 percent to 60 percent of glioblastoma patients harbor such chemotherapy-resistant tumors, which makes gene-modified stem cell transplant therapy applicable to a large number of these patients. In addition, there are also other brain ... |
